Navigation Links
Genmab's Financial Calendar for 2008
Date:1/31/2008

, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. Genmab is not under an obligation to up-date statements regarding the future following the publication of this release; nor to confirm such statements in relation to actual results, unless this is required by law.

Genmab(R); the Y-shaped Genmab logo(R); HuMax(R); HuMax-CD4(R); HuMax-CD20(R); HuMax-EGFr(TM); HuMax-IL8(TM); HuMax-TAC(TM); HuMax-HepC(TM); HuMax-CD38(TM); HuMax-CD32b(TM) and UniBody(R) are all trademarks of Genmab A/S.

Contact:

Helle Husted,

Sr. Director,

Investor Relations,

T: +45-33-44-77-30,

M: +45-25-27-47-13,

E: hth@genmab.com.


'/>"/>
SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
2. CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008
3. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
4. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
5. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
6. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
7. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
8. Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Lawrence, MA (PRWEB) August 28, 2014 “This ... single test to screen from 0 to 150 ppb,” said ... test is a significant benefit to plant owners and USDA-GIPSA ... corn and other commodities. Testing can take place in a ... Not only can the plant test the feed and grain ...
(Date:8/28/2014)... Aug. 28, 2014  Next month, executives from clinical trial ... industry events beginning with Patient-Centered Clinical Trials 2014 , ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits of ... of tactics – from media to mobile apps – can ...
(Date:8/28/2014)... BELLINGHAM, Washington, USA (PRWEB) August 27, 2014 ... Colorado next month for SPIE Laser Damage 2014 ... on optical materials for high-power lasers will run 14-17 ... international society for optics and photonics . , The ... key for understanding laser damage to optical materials will ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Whitehouse Laboratories ... long term partnership with PTI Inspection Systems ... with state of the art leak testing method development ... art instruments currently available. As part of this agreement, ... High Voltage Leak Detection Instrument developed and manufactured ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3
... N .Y. -- Using clever but elegant design, University ... can be used to capture and purify nanomaterials. , ... "bottle-brush molecule," the traps consist of tiny, organic tubes ... enables the tubes to selectively encapsulate only positively charged ...
... 5, 2011 Levi & Korsinsky is investigating potential ... Pacific Biosciences of California, Inc. ("PacBio" or the "Company") ... federal securities laws. For more information, click ... stems from allegations that the Company failed to disclose ...
... (Nasdaq: VPHM ) today announced that Robert Doody, ... the 2011 Deutsche Bank BioFEST Conference at 8:35 A.M. ET ... at the Four Seasons Hotel in Boston. Charles ... present at the Oppenheimer 22 nd Annual Healthcare Conference ...
Cached Biology Technology:Chemists become molecular sculptors, synthesizing tiny, molecular traps 2Chemists become molecular sculptors, synthesizing tiny, molecular traps 3The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc. 2
(Date:8/27/2014)... West Orange, NJ. August 27, 2014. Using functional ... shown differential brain activation patterns between people with ... the first MS study in which brain activation ... cognitive task. The article, "Neuroimaging and cognition using ... was published online on June 11 by ...
(Date:8/27/2014)... University researchers have identified a gene that could help ... a protein in the cell membrane of plants that ... water conservation machinery accordingly. , "It,s similar to ... biology at Duke. , The findings, which appear ... make it easier to feed the world,s growing population ...
(Date:8/27/2014)... Many African-Americans may not be getting effective doses of ... Hopkins suggests. The initial dosing studies, completed before the ... generally lack a protein that is key to removing ... people with maximum levels of the protein including ... maraviroc in their bodies compared to those who lack ...
Breaking Biology News(10 mins):Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Water 'thermostat' could help engineer drought-resistant crops 2Dosage of HIV drug may be ineffective for half of African-Americans 2
... protein (APP), whose cleavage product, amyloid-b (Ab), builds up ... patients, jumps from one specialized membrane microdomain to another ... there is no definitive evidence that Ab plaques are ... circumstantial evidence to support this. And working on this ...
... one step closer to finding a vaccine that better ... at Saint Louis University appears likely to offer significantly ... one in current use. "Not only was it ... better immune response, which suggests it will be more ...
... - one that,s always fatal and that has a long ... in animal models is significant. This week, Johns Hopkins ... cells into rat models of the disease clearly shifts key ... - slowing the animals, neuron loss and extending life. ...
Cached Biology News:Research identifies type of vaccine that holds promise in protecting against TB 2Swamping bad cells with good in ALS animal models helps sustain breathing 2Swamping bad cells with good in ALS animal models helps sustain breathing 3
... is a cytidine analog that has been shown ... Immunogen: Chemical / Small Molecule conjugated ... of the ddC antiserum was determined by calculating ... moles of ddC analog at the 50% intercept ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
...
... MaxiSafe 2010 Class II Biological Safety ... condition of comfort while incorporating the ... performance.,Refined operator, environment and product protection ... and recirculated air.,Bottom filters are safely ...
Biology Products: